Therapies with high success likelihood
Ineffective drug treatments before administration
Therapies you may not have already considered
Patient care planning to appropriate clinical trials
Therapies with high success likelihood
Ineffective drug treatments before administration
Therapies you may not have already considered
Patient care planning to appropriate clinical trials
Tempus delivers superior clinical utility through a combination of advanced genomic technologies that set it apart from the competition.
Eliminate false positives in somatic variant calling
Correct underrepresented populations in genomic databases
Identify somatic mutations in non-white patients accurately
Improve targeted therapies for non-white patients
Reduce inflated TMB values to prevent misuse of CPI
Report germline variants for cancer biology insights
Enable early cancer diagnosis for at-risk family members
Incorporate germline testing into screening programs
Improve gene fusion detection with RNA and DNA (29% increase with RNA sequencing
Ensure critical treatment opportunities aren't missed by capturing key gene fusions that drive tumour growth.
Identify non-overlapping actionable variants
Increase detection of clinically significant variants
Comprehensive tumour genetic profiling
Enhance treatment decision-making
Approach long-term disease management better
Track genomic changes across disease stages
Detect actionable mutations post-treatment
Optimise therapeutic interventions
Address tumour heterogeneity
Identify actionable mutations and fusions that inform targeted treatment options
Attain more context to complement genomic data by understanding tumour morphology and progression
Leverage language processing (NLP) and AI algorithms to analyse patient histories, clinical notes, and EHR data
Tempus sequences both DNA and RNA in addition to certain IHC testing to identify actionable mutations and fusions that inform targeted treatment options.
By integrating pathology and radiology results, Tempus enhances the understanding of tumour morphology and progression, giving physicians more context to complement genomic data.
Tempus uses natural language processing (NLP) and AI algorithms to analyse patient histories, clinical notes, and EHR data, ensuring that relevant clinical information is taken into account alongside molecular findings.
Tempus employs AI and machine learning models to process and interpret vast amounts of data, providing physicians with real-time insights, such as therapy recommendations and clinical trial matching, based on the patient’s unique molecular and clinical profile.
Access reports, track test status, and receive notifications from any device
An intuitive digital portal that centralises all aspects of test management
Highly personalised ordering service tailored to your needs
Bespoke customer service
At LINK Medical, we provide a highly personalised ordering service tailored to each physician’s needs. Our team manages the entire process, from sourcing the FFPE block from pathology and coordinating with labs to ensure rapid specimen shipment to arranging blood or saliva samples directly with the patient. We also support with all necessary documentation, registering the order with Tempus on behalf of the physician, and follow-up daily to address any queries promptly. Once the report is finalised, we notify the physician immediately and arrange a direct consultation with Medical Affairs to discuss any questions related to the patient’s report. This bespoke service allows physicians to focus on patient care while we manage the logistical details, providing a smooth and efficient experience.
Tempus HUB
An intuitive digital portal that centralises all aspects of test management. The platform allows for real-time tracking of test progress, allowing healthcare providers to monitor the status of patient samples and reports in real time. The platform allows for seamless integration of clinical notes, pathology results, and other relevant data, ensuring that the genomic reports are comprehensive and contextually relevant to each patient’s unique medical history.
Automated actionable insights
Once the test results are available, Tempus generates detailed yet easily interpretable reports. These reports highlight actionable mutations, potential therapeutic options, and relevant clinical trials. With a typical turnaround time of 7-10 days from sample receipt, physicians receive timely insights to support urgent decision-making. In addition to traditional PDF reports, Tempus Hub delivers additional AI-powered insights directly to physicians, harnessing the power of data from thousands of molecularly similar patient cases.
Mobile accessibility
With the Tempus mobile app, physicians can access reports, track test status, and receive notifications from anywhere, allowing for greater flexibility and real-time updates on the go. Tempus One makes accessing your patient's data so much easier with instant access to patient-specific genomic insights, therapy recommendations, and clinical trial options, allowing for data-driven decision-making at the point of care.